Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Oct
12
2023
 California’s Transformational Single-Use Packaging EPR Law Moves Toward Implementation Beveridge & Diamond PC
Oct
12
2023
 DEA Issues Second Temporary Rule Extending Controlled Substance Prescribing Flexibilities Through December 2024 Polsinelli PC
Oct
12
2023
 Cell-Cultivated Meat Is Gaining Ground Womble Bond Dickinson (US) LLP
Oct
12
2023
 DEA Further Extends Telemedicine Prescribing Flexibilities Dinsmore & Shohl LLP
Oct
12
2023
 FDA Seeks Comment on Cosmetics Direct and Forms Regarding Registration of Cosmetic Product Facility and Cosmetic Product Listing Bergeson & Campbell, P.C.
Oct
11
2023
 The U.S. Department of Labor Provides Guidance for Agricultural Employers on the PUMP Act Sheppard, Mullin, Richter & Hampton LLP
Oct
11
2023
 EC Recommends Carrying Out Risk Assessment on Biotechnologies Bergeson & Campbell, P.C.
Oct
11
2023
 FDA Updates Compliance Program for Infant Formula Keller and Heckman LLP
Oct
10
2023
 EU Proposal for a Regulation on Packaging and Packaging Waste – the Highlights Keller and Heckman LLP
Oct
10
2023
 CA Governor Newsom Signs Food Additive Ban into Law Keller and Heckman LLP
Oct
10
2023
 Assessing Compliance with EU Food-Contact Regulations: Technical Considerations
Oct
10
2023
 California Governor Signs Bill Prohibiting Certain Food Additives Greenberg Traurig, LLP
Oct
10
2023
 ACI Recognizes “Early Adopters” of Sustainable Feedstocks Initiative Bergeson & Campbell, P.C.
Oct
9
2023
 At HLTH 2023: General Catalyst’s HATCo Introduces a Radically Ambitious and Transformative Model for Healthcare Sheppard, Mullin, Richter & Hampton LLP
Oct
9
2023
 Notable New California Employment Bills Signed Into Law – Part 1 Barnes & Thornburg LLP
Oct
9
2023
 Court Strikes Down HHS Rule on Copay Accumulators: Implications for Health Plans and PBMs Mintz
Oct
9
2023
 California Bans Inquiries About Applicant Cannabis Use Jackson Lewis P.C.
Oct
9
2023
 DEA Extends Telemedicine Flexibilities for Prescribing of Controlled Medications: Second Time is the Charm Foley & Lardner LLP
Oct
7
2023
 The Tyranny of Large Numbers: Their Grip on s. 102 Inquiries
Oct
6
2023
 Federal Judge Rules Government Must Demonstrate “But-For” Causation for Anti-Kickback Statute Claims ArentFox Schiff LLP
Oct
6
2023
 Laboratory-Developed Tests: FDA Publishes Highly Anticipated Proposed Rule McDermott Will & Emery
Oct
6
2023
 CRS Report on Gene-Edited Plants Includes Issues Facing Congress Bergeson & Campbell, P.C.
Oct
6
2023
 EPA Announces 2023 Safer Choice Partner of the Year Award Winners Bergeson & Campbell, P.C.
Oct
5
2023
 Courts Continue to Grapple with the Causation Standard for False Claims Act Suits Based on Alleged Kickback Schemes, While the Supreme Court Stays on the Sidelines Mintz
Oct
5
2023
 CRS Overview of Cell-Cultivated Meat Includes Policy Considerations for Congress Bergeson & Campbell, P.C.
Oct
5
2023
 New Restrictions on Poultry and Poultry Products from France and the EU Keller and Heckman LLP
Oct
4
2023
 Key Areas of Focus in U.S.-China Relations and Their Impact on Businesses in the 118th Congress Squire Patton Boggs (US) LLP
Oct
4
2023
 Agencies Press Play on Prescription Drug Machine-Readable File Requirement Proskauer Rose LLP
Displaying 1317 - 1344 of 11745
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins